AKT1 and non-small cell lung carcinoma: EGCG combined with tyrosine kinase inhibitors (TKIs) efficiently stimulated the AMPK pathway, suppressed the ERK/MAPK and AKT/mTOR pathways, induced apoptosis, and cell cycle arrest in drug‐resistant NSCLC cells (Zhou et al. 2023).